Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to firstname.lastname@example.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 21 December 2012 | By Alexander Gaffney, RAC,
China's State Food and Drug Administration (SFDA) issued a notice to the provinces and autonomous regions on 10 December 2012 announcing the classification of 17 medical devices based on expert advice provided to the SFDA.
Two products are to be regulated as Class III (high-risk) medical devices: an ultrasound tumor therapy system and a diagnostic imaging device for the skin.
An ultrasound breast imaging diagnostic device and medical imaging software were among the ten products subjected to Class II (moderate risk) controls, and an ophthalmic surgery observation device was placed into a Class I (low risk) designation. Four products, including a pure water processing system and a medical air cleanser, were exempted from regulation as medical devices.
Tags: Classification, SFDA, Class, medical device